421 related articles for article (PubMed ID: 16000224)
1. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
Andersson K; Carlsson E
Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
[TBL] [Abstract][Full Text] [Related]
2. Developments in the inhibition of gastric acid secretion.
Mössner J; Caca K
Eur J Clin Invest; 2005 Aug; 35(8):469-75. PubMed ID: 16101666
[TBL] [Abstract][Full Text] [Related]
3. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic options in the treatment of GERD and other acid-peptic disorders. Based on a presentation by Duane D. Webb, MD, FACG.
Am J Manag Care; 2000 May; 6(9 Suppl):S467-75. PubMed ID: 10977486
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and acid-related diseases.
Sachs G
Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors: the beginning of the end or the end of the beginning?
Scarpignato C; Hunt RH
Curr Opin Pharmacol; 2008 Dec; 8(6):677-84. PubMed ID: 18840545
[TBL] [Abstract][Full Text] [Related]
8. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
Inatomi N; Matsukawa J; Sakurai Y; Otake K
Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
[TBL] [Abstract][Full Text] [Related]
9. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
Robinson M
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease (GERD): is there more to the story?
Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
[TBL] [Abstract][Full Text] [Related]
12. Current status of acid pump antagonists (reversible PPIs).
Wurst W; Hartmann M
Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
[TBL] [Abstract][Full Text] [Related]
13. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
14. Improving on PPI-based therapy of GORD.
Sachs G
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S35-41. PubMed ID: 11430507
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
16. Biological basis of omeprazole therapy.
Sachs G; Wallmark B
J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches to reflux disease, focusing on acid secretion.
Kinoshita Y; Adachi K; Fujishiro H
J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological targets in gastro-oesophageal reflux disease.
Piche T; Galmiche JP
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):333-41. PubMed ID: 16364047
[TBL] [Abstract][Full Text] [Related]
19. Optimizing acid-suppression therapy.
Barnett JL; Robinson M
Manag Care; 2001 Oct; 10(10 Suppl):17-21. PubMed ID: 11729443
[TBL] [Abstract][Full Text] [Related]
20. New pharmacologic approaches in gastroesophageal reflux disease.
Armstrong D; Sifrim D
Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
